LABCORP PRICES $650,000,000 IN 4.350% SENIOR NOTES DUE 2030, $500,000,000 IN 4.550% SENIOR NOTES DUE 2032 AND $850,000,000 IN 4.800% SENIOR NOTES DUE 2034

Core Viewpoint - Labcorp Holdings Inc. announced the pricing of a $2 billion senior notes offering through its subsidiary, Laboratory Corporation of America Holdings, with three tranches maturing in 2030, 2032, and 2034 [1][3]. Group 1: Offering Details - The offering consists of $650 million of 4.350% Senior Notes due 2030, $500 million of 4.550% Senior Notes due 2032, and $850 million of 4.800% Senior Notes due 2034 [1]. - The notes will bear interest from September 23, 2024, payable semi-annually starting April 1, 2025 [1]. - The 2030 Notes will be issued at 99.931% of par value, the 2032 Notes at 99.608%, and the 2034 Notes at 99.755% [1]. Group 2: Use of Proceeds - Labcorp plans to use the net proceeds to redeem or repay existing indebtedness, including $400 million of 2.30% Senior Notes due December 1, 2024, and $1 billion of 3.60% Senior Notes due February 1, 2025 [3]. - Additionally, $350 million will be used to repay borrowings under its revolving credit facility, with any remaining funds allocated for general corporate purposes [3]. Group 3: Regulatory and Management Information - The offering will be made under an effective shelf registration statement filed with the SEC, including a base prospectus and a prospectus supplement [2]. - The joint book-running managers for the offering include BofA Securities, US Bancorp, and Wells Fargo Securities, among others [4].